Background:

Cardiology has a leading role in the control and treatment of persons with type 2 diabetes mellitus (DM2). We do not have local epidemiological data about patients with DM2 treated by cardiologists.

Objectives:

The aim of this study was to evaluate the clinical characteristics, cardiovascular disease (CVD) and treatment of patients with DM2 attending a cardiology office.

Methods:

We conducted and observational study in 17 provinces of Argentina during three months.

Results:

A total of 694 patients were included in the study. Mean age was 64.7±10.5 years, time of disease progression 10.7±9.3 years, body mass index 32±5.9 kg/m2, HbA1c 7.3%±1.6, and blood pressure 135/80 mm Hg. Seventy percent of the patients presented two or more risk factors, 48.1% had CVD and microvascular disease was present in 40.9% of cases (kidney disease in 31.4%, retinopathy in 10.5%, neuropathy in 8.3% and diabetic foot in 3.3%). Patients were receiving antiplatelet agents in 57.3% of cases, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) in 84.3% and 79.5% were treated with statins. Hypoglycemic agents included metformin in 85.9% of patients, dipeptidyl peptidase 4 (DPP4) inhibitors in 24.1%, sulfonylureas (SU) in 14.3%, sodium-glucose co-transporter 2 (SGLT2) inhibitors in 9.8%, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in 3% and glitazones in 1.3%. HbA1C levels ≤7% were achieved by 55.9% of patients, BP <140/90 mm Hg by 61.7%, and LDL-C <100 mg/dL by 58.5% and <70 mg/dL by 28.5%.

Conclusions:

Most patients with DM2 presented two or more cardiovascular risk factors and a high prevalence of associated complications. Treatment goals were achieved by a low number of patients and the use of medications with demonstrated cardiovascular benefit was low.

        · resumen en Español     · texto en Español     · Español ( pdf ) | Inglés ( pdf )